Abstract
A recent paper in PNAS (Swijnenburg et al., 2008) reveals that human embryonic stem cells are not immune privileged. Potential therapeutic use of these cells will thus depend on the development of new strategies to counter foreign graft rejection by patient immune systems.
Publication types
-
Introductory Journal Article
MeSH terms
-
Animals
-
Cell Differentiation / immunology*
-
Embryonic Stem Cells / cytology
-
Embryonic Stem Cells / immunology*
-
Graft Rejection / immunology
-
Histocompatibility Antigens / genetics
-
Histocompatibility Antigens / metabolism*
-
Humans
-
Immune Tolerance / immunology*
-
Immunity, Active
-
Immunohistochemistry
-
Luminescent Proteins
-
Mice
-
Stem Cell Transplantation
-
Time Factors
-
Transplantation Immunology
-
Transplantation, Homologous
Substances
-
Histocompatibility Antigens
-
Luminescent Proteins